Gyrodyne, LLC — Q2 2022 Form 10-Q Summary
Reporting period: Quarter ended June 30, 2022. The filing’s financial statements are on a liquidation basis and principally report net assets and changes in net assets for the six months ended June 30; it does not provide a conventional quarterly income statement or cash-flow statement.
Business context
Gyrodyne is managing and seeking entitlements for its remaining New York properties—Flowerfield, a 63-acre site including a 135,000-square-foot industrial park, and Cortlandt Manor, a 13.8-acre site with a medical center. Its plan is to sell the properties, settle liabilities, distribute remaining proceeds to shareholders, and dissolve.
Financial position and activity
| Metric | June 30, 2022 | Comparison / detail |
|---|---|---|
| Real estate held for sale | $42.545 million | Unchanged from December 31, 2021 |
| Cash and cash equivalents | $4.806 million | Down from $5.671 million at December 31, 2021 |
| Total assets | $47.455 million | Down from $48.284 million |
| Total liabilities | $24.475 million | Down from $25.256 million |
| Net assets in liquidation | $22.980 million | Down $47,751 from year-end 2021 |
| Estimated liquidation value per share | Approximately $15.50 | Down from $15.53; based on 1,482,680 shares |
- Six-month operating cash-flow items disclosed: $1.503 million in rent and reimbursements, $907,538 in operating costs, and $595,489 in net operating income. The filing reports $1.087 million in corporate expenditures, $210,476 in interest expense, $104,317 in real-estate capital expenditures, and $185,607 in entitlement costs. These figures are not a complete cash-flow statement.
- Debt: Loans payable totaled $9.895 million, versus $10.029 million at year-end 2021. The Flowerfield facilities carry a fixed 3.85% rate; the Cortlandt mortgage carries 3.75% through its initial term. The company reported compliance with loan covenants.
- Profit and margins: Not presented as conventional income-statement measures under the liquidation basis; the filing does not provide clear quarterly revenue or profit figures.
Changes, outlook, and material matters
- The $47,751 decrease in net assets was attributed to remeasurement of assets and liabilities, including an estimated approximately $500,000 in legal fees to defend the Flowerfield challenge and other cost changes, partly offset by approximately $480,000 of additional estimated revenue, including about $370,000 associated with new leases or expansions.
- Smithtown’s Planning Board unanimously granted preliminary approval in March 2022 for an eight-lot Flowerfield subdivision. In April, the Village of Head of the Harbor and others filed an Article 78 proceeding seeking to annul the environmental findings and preliminary approval. Gyrodyne and the Town are defending the approvals; the proceeding could take two years or more.
- Management expected final subdivision approvals for Flowerfield and Cortlandt Manor in late 2022 or early 2023, and estimated that property sales, final approvals, and liquidation could be completed by year-end 2024. These are estimates, not assurances.
- Management estimated liquidation distributions of approximately $15.50 per share, based on June 30 estimates. The estimate includes projected gross real-estate proceeds of $42.55 million and incorporates selling costs, debt repayment, operating and entitlement costs, retention bonuses, and other liquidation expenses. Actual proceeds and timing may differ materially; the estimate is not a promised distribution.
- Management forecast approximately $1.18 million of additional entitlement costs through the estimated liquidation period. It intends to position the properties for sale, not develop them, and may consider offers before completing the entitlement process.
- Risks include the Article 78 case, community opposition, delays in approvals, environmental issues, labor shortages, real-estate market conditions, inflation, higher interest rates, recession risk, and COVID-19 impacts. The three largest tenants represented approximately 23%, 21%, and 8% of six-month rental income; tenants not affiliated with a major hospital represented about 41% of projected 2022 rental revenue.
- Disclosure controls were deemed ineffective because of a material weakness in controls over valuation of real estate held for sale. Management said the weakness did not cause a material misstatement and described remediation steps, but had not yet concluded that remediation was complete.
Important facts for investors to verify
- Progress and outcome of the Article 78 proceeding, and whether preliminary Flowerfield approval remains effective.
- Final subdivision and site-plan approvals, sale timing, and whether management’s year-end 2024 liquidation estimate remains achievable.
- Assumptions underlying the $42.545 million real-estate valuation and the estimated $15.50-per-share distribution, including sale prices, costs, and liabilities.
- Cash needs, debt repayment and maturity terms, deferred vendor payments, and whether available funds remain adequate through liquidation.
- Whether the real-estate valuation control weakness is remediated and tested as effective.